VESICARE LS FDA approval date
The FDA approved VESICARE LS on 26 May 2020.
- FDA approval date
- 26 May 2020
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as SOLIFENACIN SUCCINATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2020-05-26Day | VESICARE LS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209529", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["VESICARE LS"], "active_ingredients": ["SOLIFENACIN SUCCINATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200526", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |